RELAPSED ADVANCED LYMPHOMAS
Clinical trials for RELAPSED ADVANCED LYMPHOMAS explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ADVANCED LYMPHOMAS trials appear
Sign up with your email to follow new studies for RELAPSED ADVANCED LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill hopes to fight advanced lymphoma when other treatments fail
Disease control Recruiting nowThis early-phase study tests an experimental oral drug, AUR112, in adults with relapsed advanced lymphoma that has not responded to prior treatments. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. About 40 participants will …
Matched conditions: RELAPSED ADVANCED LYMPHOMAS
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New pill aims to tame relapsed lymphomas in early trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called AUR108 in adults with relapsed advanced lymphomas (cancers of the lymph system). The main goals are to check the drug's safety, find the best dose, and see how the body processes it. About 40 participants will take the…
Matched conditions: RELAPSED ADVANCED LYMPHOMAS
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC